These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1333018)

  • 1. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
    Smit VT; Fleuren GJ; van Houwelingen JC; Zegveld ST; Kuipers-Dijkshoorn NJ; Cornelisse CJ
    Cancer; 1990 Oct; 66(8):1843-9. PubMed ID: 2208040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Image analysis of DNA cytometry for assessing prognosis after resection of esophageal cancer].
    Böttger T; Störkel S; Stöckle M; Wahl W; Heintz A; Jugenheimer M; Effenberger-Kim O; Vinh T; Junginger T
    Chirurg; 1991 Jun; 62(6):467-72; discussion 472-3. PubMed ID: 1655366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
    Corver WE; Bonsing BA; Abeln EC; Vlak-Theil PM; Cornelisse CJ; Fleuren GJ
    Cytometry; 1996 Dec; 25(4):358-66. PubMed ID: 8946143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferative activity assessed on the basis of DNA ploidy patterns in primary lung cancer].
    Yamaoka N; Tagawa Y; Miyashita K; Ayabe H; Kawahara K; Uchiyama Y; Tomita M
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):598-602. PubMed ID: 1875901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytometric analysis of the DNA ploidy pattern of primary lung cancer--its prognostic and biological implications].
    Shiba M; Yamaguchi Y
    Nihon Rinsho; 1992 Oct; 50(10):2395-400. PubMed ID: 1447809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathologic status as a prognostic factor in ovarian cancer].
    Schieder K; Breitenecker G; Köbl H; Bieglmayer C
    Gynakol Rundsch; 1990; 30 Suppl 1():147-50. PubMed ID: 1964147
    [No Abstract]   [Full Text] [Related]  

  • 20. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
    Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
    Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.